Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2012, Article ID 767105, 9 pages
http://dx.doi.org/10.1155/2012/767105
Review Article

Bright Light Therapy in Parkinson's Disease: An Overview of the Background and Evidence

1Department of Psychiatry, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
2Department of Anatomy and Neuroscience, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
3Department of Neurology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
4Department of Sleep and Cognition, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences, Meibergdreef 47, 1105 BA Amsterdam, The Netherlands

Received 27 September 2012; Revised 16 November 2012; Accepted 21 November 2012

Academic Editor: Douglas Mckay Wallace

Copyright © 2012 Sonja Rutten et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Park and M. Stacy, “Non-motor symptoms in Parkinson's disease,” Journal of Neurology, vol. 256, no. 3, supplement, pp. 293–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Rodriguez-Oroz, M. Jahanshahi, P. Krack et al., “Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms,” The Lancet Neurology, vol. 8, no. 12, pp. 1128–1139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. K. R. Chaudhuri, D. G. Healy, and A. H. V. Schapira, “Non-motor symptoms of Parkinson's disease: diagnosis and management,” The Lancet Neurology, vol. 5, no. 3, pp. 235–245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Dauvilliers, “Insomnia in patients with neurodegenerative conditions,” Sleep Medicine, vol. 8, supplement 4, pp. S27–S34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Menza, R. D. Dobkin, H. Marin, and K. Bienfait, “Sleep disturbances in Parkinson's disease,” Movement Disorders, vol. 25, supplement 1, pp. S117–S122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Larsen and E. Tandberg, “Sleep disorders in patients with Parkinson's disease: epidemiology and management,” CNS Drugs, vol. 15, no. 4, pp. 267–275, 2001. View at Google Scholar · View at Scopus
  7. E. Tandberg, J. P. Larsen, and K. Karlsen, “Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study,” Movement Disorders, vol. 14, no. 6, pp. 922–927, 1999. View at Google Scholar
  8. G. L. Willis, C. Moore, and S. M. Armstrong, “A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson's disease,” Reviews in the Neurosciences, vol. 23, no. 2, pp. 199–226, 2012. View at Publisher · View at Google Scholar
  9. D. Aarsland, S. Pahlhagen, C. G. Ballard, U. Ehrt, and P. Svenningsson, “Depression in Parkinson disease—epidemiology, mechanisms and management,” Nature Reviews Neurology, vol. 8, no. 1, pp. 35–47, 2012. View at Google Scholar
  10. J. L. Cummings, “Depression and Parkinson's disease: a review,” American Journal of Psychiatry, vol. 149, no. 4, pp. 443–454, 1992. View at Google Scholar · View at Scopus
  11. A. Schrag, M. Jahanshahi, and N. Quinn, “What contributes to quality of life in patients with Parkinson's disease?” Journal of Neurology, Neurosurgery & Psychiatry, vol. 69, no. 3, pp. 308–312, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. K. H. Karlsen, J. P. Larsen, E. Tandberg, and J. G. Maeland, “Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 66, no. 4, pp. 431–435, 1999. View at Google Scholar · View at Scopus
  13. J. J. M. Askenasy, “Sleep in Parkinson's disease,” Acta Neurologica Scandinavica, vol. 87, no. 3, pp. 167–170, 1993. View at Google Scholar · View at Scopus
  14. M. Caap-Ahlgren and O. Dehlin, “Insomnia and depressive symptoms in patients with Parkinson's disease: relationship to health-related quality of life. An interview study of patients living at home,” Archives of Gerontology and Geriatrics, vol. 32, no. 1, pp. 23–33, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. B. Aerts, M. van der Eijk, K. Kramers, and B. R. Bloem, “Insufficient medication compliance in Parkinson's disease,” Nederlands Tijdschrift voor Geneeskunde, vol. 155, p. A3031, 2011. View at Google Scholar · View at Scopus
  16. M. J. Thorpy, “Sleep disorders in Parkinson's disease,” Clinical Cornerstone, vol. 6, no. 1, pp. S7–S15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. G. A. Dowling, J. Mastick, E. Colling, J. H. Carter, C. M. Singer, and M. J. Aminoff, “Melatonin for sleep disturbances in Parkinson's disease,” Sleep Medicine, vol. 6, no. 5, pp. 459–466, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. A. M. Medeiros, P. F. Carvalhedo de Bruin, L. A. Lopes, M. C. Magalhães, M. de Lourdes Seabra, and V. M. Sales de Bruin, “Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease: a randomized, double blind, placebo-controlled study,” Journal of Neurology, vol. 254, no. 4, pp. 459–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Bordet, D. Devos, S. Brique et al., “Study of circadian melatonin secretion pattern at different stages of Parkinson's disease,” Clinical Neuropharmacology, vol. 26, no. 2, pp. 65–72, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Chen, E. Schernhammer, M. A. Schwarzschild, and A. Ascherio, “A prospective study of night shift work, sleep duration, and risk of Parkinson's disease,” American Journal of Epidemiology, vol. 163, no. 8, pp. 726–730, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. D. Catalá, C. Cañete-Nicolás, A. Iradi, F. J. Tarazona, J. M. Tormos, and A. Pascual-Leone, “Melatonin levels in Parkinson's disease: drug therapy versus electrical stimulation of the internal globus pallidus,” Experimental Gerontology, vol. 32, no. 4-5, pp. 553–558, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. G. L. Willis and S. M. Armstrong, “A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease,” Physiology and Behavior, vol. 66, no. 5, pp. 785–795, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. F. J. E. Vajda and C. Solinas, “Current approaches to management of depression in Parkinson's disease,” Journal of Clinical Neuroscience, vol. 12, no. 7, pp. 739–743, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Madhusoodanan, L. Alexeenko, R. Sanders, and R. Brenner, “Extrapyramidal symptoms associated with antidepressants—a review of the literature and an analysis of spontaneous reports,” Annals of Clinical Psychiatry, vol. 22, no. 3, pp. 148–156, 2010. View at Google Scholar · View at Scopus
  25. I. H. Richard, M. P. McDermott, R. Kurlan, J. M. Lyness, P. G. Como, N. Pearson et al., “A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease,” Neurology, vol. 78, no. 16, pp. 1229–1236, 2012. View at Google Scholar
  26. C. L. Deschenes and S. M. McCurry, “Current treatments for sleep disturbances in individuals with dementia,” Current Psychiatry Reports, vol. 11, no. 1, pp. 20–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Pahwa, “Understanding Parkinson's disease: an update on current diagnostic and treatment strategies,” Journal of the American Medical Directors Association, vol. 7, supplement 2, no. 7, pp. 4–10, 2006. View at Google Scholar · View at Scopus
  28. D. Aarsland, J. Zaccai, and C. Brayne, “A systematic review of prevalence studies of dementia in Parkinson's disease,” Movement Disorders, vol. 20, no. 10, pp. 1255–1263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Monteleone and M. Maj, “The circadian basis of mood disorders: recent developments and treatment implications,” European Neuropsychopharmacology, vol. 18, no. 10, pp. 701–711, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Baglioni, K. Spiegelhalder, C. Lombardo, and D. Riemann, “Sleep and emotions: a focus on insomnia,” Sleep Medicine Reviews, vol. 14, no. 4, pp. 227–238, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. R. N. Golden, B. N. Gaynes, R. D. Ekstrom et al., “The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence,” American Journal of Psychiatry, vol. 162, no. 4, pp. 656–662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Lieverse, E. J. W. van Someren, M. M. A. Nielen, B. M. J. Uitdehaag, J. H. Smit, and W. J. G. Hoogendijk, “Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial,” Archives of General Psychiatry, vol. 68, no. 1, pp. 61–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. R. F. Riemersma-van der Lek, D. F. Swaab, J. Twisk, E. M. Hol, W. J. G. Hoogendijk, and E. J. W. van Someren, “Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial,” The Journal of the American Medical Association, vol. 299, no. 22, pp. 2642–2655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. S. Campbell, D. Dawson, and M. W. Anderson, “Alleviation of sleep maintenance insomnia with timed exposure to bright light,” Journal of the American Geriatrics Society, vol. 41, no. 8, pp. 829–836, 1993. View at Google Scholar · View at Scopus
  35. K. Mishima, M. Okawa, Y. Hishikawa, S. Hozumi, H. Hori, and K. Takahashi, “Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia,” Acta Psychiatrica Scandinavica, vol. 89, no. 1, pp. 1–7, 1994. View at Google Scholar · View at Scopus
  36. G. Pail, W. Huf, E. Pjrek et al., “Bright-light therapy in the treatment of mood disorders,” Neuropsychobiology, vol. 64, no. 3, pp. 152–162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Satlin, L. Volicer, V. Ross, L. Herz, and S. Campbell, “Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease,” American Journal of Psychiatry, vol. 149, no. 8, pp. 1028–1032, 1992. View at Google Scholar · View at Scopus
  38. A. Wirz-Justice, F. Benedetti, M. Berger et al., “Chronotherapeutics (light and wake therapy) in affective disorders,” Psychological Medicine, vol. 35, no. 7, pp. 939–944, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Paus, T. Schmitz-Hübsch, U. Wüllner, A. Vogel, T. Klockgether, and M. Abele, “Bright light therapy in Parkinson's disease: a pilot study,” Movement Disorders, vol. 22, no. 10, pp. 1495–1498, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. G. L. Willis and E. J. D. Turner, “Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study,” Chronobiology International, vol. 24, no. 3, pp. 521–537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. D. K. Welsh, D. E. Logothetis, M. Meister, and S. M. Reppert, “Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms,” Neuron, vol. 14, no. 4, pp. 697–706, 1995. View at Google Scholar · View at Scopus
  42. A. M. Rosenwasser, “Functional neuroanatomy of sleep and circadian rhythms,” Brain Research Reviews, vol. 61, no. 2, pp. 281–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Arendt and D. J. Skene, “Melatonin as a chronobiotic,” Sleep Medicine Reviews, vol. 9, no. 1, pp. 25–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. R. Pandi-Perumal, I. Trakht, V. Srinivasan et al., “Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways,” Progress in Neurobiology, vol. 85, no. 3, pp. 335–353, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. E. J. W. van Someren, “Circadian and sleep disturbances in the elderly,” Experimental Gerontology, vol. 35, no. 9-10, pp. 1229–1237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Cajochen, M. Münch, V. Knoblauch, K. Blatter, and A. Wirz-Justice, “Age-related changes in the circadian and homeostatic regulation of human sleep,” Chronobiology International, vol. 23, no. 1-2, pp. 461–474, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Wirz-Justice, “Diurnal variations of depressive symptoms,” Dialogues in Clinical Neuroscience, vol. 10, no. 3, pp. 337–343, 2008. View at Google Scholar · View at Scopus
  48. C. A. McClung, “Circadian genes, rhythms and the biology of mood disorders,” Pharmacology and Therapeutics, vol. 114, no. 2, pp. 222–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. P. L. Franzen, D. J. Buysse, R. E. Dahl, W. Thompson, and G. J. Siegle, “Sleep deprivation alters pupillary reactivity to emotional stimuli in healthy young adults,” Biological Psychology, vol. 80, no. 3, pp. 300–305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. D. J. Buysse, E. Frank, K. K. Lowe, C. R. Cherry, and D. J. Kupfer, “Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression,” Biological Psychiatry, vol. 41, no. 4, pp. 406–418, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. C. A. Espie, “Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults,” Annual Review of Psychology, vol. 53, pp. 215–243, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. P. L. Franzen, G. J. Siegle, and D. J. Buysse, “Relationships between affect, vigilance, and sleepiness following sleep deprivation,” Journal of Sleep Research, vol. 17, no. 1, pp. 34–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Kales, A. B. Caldwell, T. A. Preston et al., “Personality patterns in insomnia. Theoretical implications,” Archives of General Psychiatry, vol. 33, no. 9, pp. 1128–1134, 1976. View at Publisher · View at Google Scholar · View at Scopus
  54. M. P. Walker and E. van der Helm, “Overnight therapy? The role of sleep in emotional brain processing,” Psychological Bulletin, vol. 135, no. 5, pp. 731–748, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Zohar, O. Tzischinsky, R. Epstein, and P. Lavie, “The effects of sleep loss on medical residents' emotional reactions to work events: a cognitive-energy model,” Sleep, vol. 28, no. 1, pp. 47–54, 2005. View at Google Scholar · View at Scopus
  56. K. J. Maloney, E. G. Cape, J. Gotman, and B. E. Jones, “High-frequency γ electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat,” Neuroscience, vol. 76, no. 2, pp. 541–555, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. E. G. Cape and B. E. Jones, “Differential modulation of high-frequency γ-electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons,” Journal of Neuroscience, vol. 18, no. 7, pp. 2653–2666, 1998. View at Google Scholar · View at Scopus
  58. S. S. Yoo, N. Gujar, P. Hu, F. A. Jolesz, and M. P. Walker, “The human emotional brain without sleep—a prefrontal amygdala disconnect,” Current Biology, vol. 17, no. 20, pp. R877–R878, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. E. van der Helm, J. Yao, S. Dutt, V. Rao, J. M. Saletin, and M. P. Walker, “REM sleep depotentiates amygdala activity to previous emotional experiences,” Current Biology, vol. 21, no. 23, pp. 2029–2032.
  60. E. van der Helm, J. Yao, S. Dutt, V. Rao, J. M. Saletin, and M. P. Walker, “REM sleep depotentiates amygdala activity to previous emotional experiences,” Current Biology, vol. 21, no. 23, pp. 2029–2032, 2011. View at Publisher · View at Google Scholar
  61. M. Imbesi, S. Yildiz, A. Dirim Arslan, R. Sharma, H. Manev, and T. Uz, “Dopamine receptor-mediated regulation of neuronal “clock” gene expression,” Neuroscience, vol. 158, no. 2, pp. 537–544, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Hampp, J. A. Ripperger, T. Houben et al., “Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood,” Current Biology, vol. 18, no. 9, pp. 678–683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Hood, P. Cassidy, M. P. Cossette et al., “Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors,” Journal of Neuroscience, vol. 30, no. 42, pp. 14046–14058, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Sakamoto, C. Liu, M. Kasamatsu, N. V. Pozdeyev, P. M. Iuvone, and G. Tosini, “Dopamine regulates melanopsin mRNA expression in intrinsically photosensitive retinal ganglion cells,” European Journal of Neuroscience, vol. 22, no. 12, pp. 3129–3136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. P. L. Turner and M. A. Mainster, “Circadian photoreception: ageing and the eye's important role in systemic health,” British Journal of Ophthalmology, vol. 92, no. 11, pp. 1439–1444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Hartmann, J. D. Veldhuis, M. Deuschle, H. Standhardt, and I. Heuser, “Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation,” Neurobiology of Aging, vol. 18, no. 3, pp. 285–289, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Devos, M. Kroumova, R. Bordet et al., “Heart rate variability and Parkinson's disease severity,” Journal of Neural Transmission, vol. 110, no. 9, pp. 997–1011, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. C. H. Adler and M. J. Thorpy, “Sleep issues in Parkinson's disease,” Neurology, vol. 64, supplement 3, no. 12, pp. S12–S20, 2005. View at Google Scholar · View at Scopus
  69. B. Bruguerolle and N. Simon, “Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function,” Clinical Neuropharmacology, vol. 25, no. 4, pp. 194–201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. E. Fertl, E. Auff, A. Doppelbauer, and F. Waldhauser, “Circadian secretion pattern of melatonin in de novo Parkinsonian patients: evidence for phase-shifting properties of l-dopa,” Journal of Neural Transmission, vol. 5, no. 3, pp. 227–234, 1993. View at Google Scholar · View at Scopus
  71. E. Fertl, E. Auff, A. Doppelbauer, and F. Waldhauser, “Circadian secretion pattern of melatonin in Parkinson's disease,” Journal of Neural Transmission, vol. 3, no. 1, pp. 41–47, 1991. View at Google Scholar · View at Scopus
  72. A. O. Kogan and P. M. Guilford, “Side effects of short-term 10,000-lux light therapy,” American Journal of Psychiatry, vol. 155, no. 2, pp. 293–294, 1998. View at Google Scholar · View at Scopus
  73. A. R. Artemenko and I. Levin Ia, “The phototherapy of parkinsonism patients,” Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, vol. 96, no. 3, pp. 63–66, 1996. View at Google Scholar
  74. C. Sobin and H. A. Sackeim, “Psychomotor symptoms of depression,” American Journal of Psychiatry, vol. 154, no. 1, pp. 4–17, 1997. View at Google Scholar · View at Scopus
  75. C. M. Morin, P. J. Hauri, C. A. Espie, A. J. Spielman, D. J. Buysse, and R. R. Bootzin, “Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review,” Sleep, vol. 22, no. 8, pp. 1134–1156, 1999. View at Google Scholar · View at Scopus
  76. C. M. Morin, R. R. Bootzin, D. J. Buysse, J. D. Edinger, C. A. Espie, and K. L. Lichstein, “Psychological and behavioral treatment of insomnia: update of the recent evidence (1998–2004),” Sleep, vol. 29, no. 11, pp. 1398–1414, 2006. View at Google Scholar · View at Scopus
  77. M. Terman, J. S. Terman, and D. C. Ross, “A controlled trial of timed bright light and negative air ionization for treatment of winter depression,” Archives of General Psychiatry, vol. 55, no. 10, pp. 875–882, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Wirz-Justice, F. Benedetti, M. Terman et al., “Chronotherapeutics (light and wake therapy) in affective disorders,” Psychological Medicine, vol. 35, no. 7, pp. 939–944, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. J. S. Terman, M. Terman, D. Schlager et al., “Efficacy of brief, intense light exposure for treatment of winter depression,” Psychopharmacology Bulletin, vol. 26, no. 1, pp. 3–11, 1990. View at Google Scholar · View at Scopus
  80. M. Terman and J. S. Terman, “Light therapy,” in Principles and Practice of Sleep Medicine, Elsevier, Philadelphia, Pa, USA, 2005. View at Google Scholar
  81. M. Terman, C. E. Remé, B. Rafferty, P. F. Gallin, and J. S. Terman, “Bright light therapy for winter depression: potential ocular effects and theoretical implications,” Photochemistry and Photobiology, vol. 51, no. 6, pp. 781–792, 1990. View at Google Scholar · View at Scopus
  82. A. Wirz-Justice, F. Benedetti, and M. Terman, “Inpatient procedures,” in Chronotherapeutics for Affective Disorders, Karger, Basel, Switzerland, 2009. View at Google Scholar
  83. J. A. Horne and O. Ostberg, “A self assessment questionnaire to determine morningness eveningness in human circadian rhythms,” International Journal of Chronobiology, vol. 4, no. 2, pp. 97–110, 1976. View at Google Scholar · View at Scopus
  84. P. F. Gallin, M. Terman, C. E. Reme, B. Rafferty, J. S. Terman, and R. M. Burde, “Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy,” American Journal of Ophthalmology, vol. 119, no. 2, pp. 202–210, 1995. View at Google Scholar · View at Scopus
  85. J. Schwitzer, C. Neudorfer, H. G. Blecha, and W. W. Fleischhacker, “Mania as a side effect of phototherapy,” Biological Psychiatry, vol. 28, no. 6, pp. 532–534, 1990. View at Publisher · View at Google Scholar · View at Scopus
  86. D. F. Kripke, “Timing of phototherapy and occurrence of mania,” Biological Psychiatry, vol. 29, no. 11, pp. 1156–1157, 1991. View at Google Scholar · View at Scopus